158984-84-0

Basic information

• Product Name: tert-butyl 6-(trifluoroMethylsulfonyloxy)-3,4-dihydroisoquinoline-2(1H)-carboxylate
• Synonyms: tert-butyl 6-(trifluoroMethylsulfonyloxy)-3,4-dihydroisoquinoline-2(1H)-carboxylate;tert-butyl 6-(trifluoroMethylsulfonyloxy)-3,4-dihydroisoquinoline-2(1H)-carboxylate-11
• CAS NO: 158984-84-0
• Molecular Formula: C₁₅H₁₈F₃NO₅S
• Molecular Weight: 381.3673296
• Mol File: 158984-84-0.mol
• Article Data: 19

Chemical Properties

• Melting Point: 48-51 °C
• Boiling Point: 430.9±45.0 °C(Predicted)
• Appearance: /
• Density: 1.382±0.06 g/cm3(Predicted)
• PKA: -1?+-.0.20(Predicted)
• CAS DataBase Reference: tert-butyl 6-(trifluoroMethylsulfonyloxy)-3,4-dihydroisoquinoline-2(1H)-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl 6-(trifluoroMethylsulfonyloxy)-3,4-dihydroisoquinoline-2(1H)-carboxylate(158984-84-0)
• EPA Substance Registry System: tert-butyl 6-(trifluoroMethylsulfonyloxy)-3,4-dihydroisoquinoline-2(1H)-carboxylate(158984-84-0)

Safety Data

• Hazardous Substances Data: 158984-84-0(Hazardous Substances Data)

Usage

General Description

"Tert-butyl 6-(trifluoroMethylsulfonyloxy)-3,4-dihydroisoquinoline-2(1H)-carboxylate" is a chemical compound that falls under the class of carboxylates. It contains a tert-butyl group, a trifluoromethylsulfonyloxy group, and a dihydroisoquinoline-2(1H)-carboxylate group. The tert-butyl group is a common substituent in organic chemistry, while the trifluoromethylsulfonyloxy group is often used as a leaving group in chemical reactions. The dihydroisoquinoline-2(1H)-carboxylate group is a fused bicyclic heterocyclic compound with potential biological and pharmaceutical applications. Overall, this complex compound has the potential for use in various chemical reactions and as a precursor for the synthesis of other organic compounds.

Upstream product

• 358-23-6 trifluoromethylsulfonic anhydride 
• 158984-83-9 N-tert-butoxycarbonyl-6-hydroxy-1,2,3,4-tetrahydroisoquinoline 
• 24424-99-5 di-tert-butyl dicarbonate 
• 63905-73-7 6-hydroxy-1,2,3,4-tetrahydroisoquinoline hydrochloride 
• 59839-23-5 6-hydroxy-1,2,3,4-tetrahydroisoquinoline hydrobromide 
• 37595-74-7 N,N-phenylbistrifluoromethane-sulfonimide 
• 22246-12-4 6-methoxy-1,2,3,4-tetrahydro-1-oxoisoquinoline 
• 42923-77-3 6-methoxy-1,2,3,4-tetrahydro-isoquinoline 
• 14446-24-3 6-hydroxy-1,2,3,4-tetrahydroisoquinoline 

Downstream Products

• 166398-33-0 tert-butyl 6-cyano-3,4-dihydroisoquinoline-2(1H)-carboxylate 
• 170097-66-2 3,4-Dihydro-1H-isoquinoline-2.6-dicarboxylic acid 2-tert-butyl ester-6-methyl ester 
• 949922-27-4 1-(1,2,3,4-tetrahydroisoquinolin-6-yl)ethanone 
• 170097-67-3 2-(tert-butoxycarbonyl)-1,2,3,4-tetrahydroisoquinoline-6-carboxylic acid 
• 189745-24-2 6-(4-chlorophenyl)-3,4-dihydro-1H-isoquinoline-2-carboxylic acid tert-butyl ester 
• 189745-26-4 tert.-butyl 6-(3,5-dichlorophenyl)-3,4-dihydro-1H-isoquinoline-2-carboxylate 
• 893566-72-8 6-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-3,4-dihydro-1H-isoquinoline-2-carboxylic acid tert-butyl ester 
• 1007579-56-7 1,1-dimethylethyl 6-[3-(aminocarbonyl)phenyl]-3,4-dihydro-2(1H)-isoquinolinecarboxylate 
• 1007579-62-5 3-(1,2,3,4-tetrahydro-6-isoquinolinyl)benzamide 

Relevant articles and documents

Electrochemical Approach for Direct C-H Phosphonylation of Unprotected Secondary Amine

Direct α-phosphonylation of an unprotected secondary amine in a single step is of practical importance to amino phophophates. However, this protocol is limited due to the high redox barrier of unprotected amine. In this paper, we report C-H phosphonylation of an unprotected secondary amine via an electrochemical approach in the presence of catalytic carboxylate salt. This metal-free and exogenous oxidant-free method furnishes diverse target molecules with satisfactory yield under mild reaction conditions. Successful application of the protocol in a gram-scale experiment demonstrates the potential utility for further functionalization.

T-type calcium channel inhibitor

The present invention addresses the problem of providing novel compounds that have T-type voltage-gated calcium channel-blocking activity and are useful particularly in treating pain, chronic kidney disease, and atrial fibrillation. Provided are novel tri

As opioid receptor antagonists or inverse agonists of the novel compounds

Novel compounds which are antagonists or inverse agonists at one or more of the opioid receptors, pharmaceutical compositions containing them, to processes for their preparation.